Although urinary tract infections (UTIs) are typically minor—albeit painful—health issues for most people, they can pose serious risks for older adults, particularly those with Alzheimer's disease and ...
Researchers in Japan built a miniature human brain circuit using fused stem-cell–derived organoids, allowing them to watch the thalamus and cortex interact in real time. They found that the thalamus ...
While changing perspectives for adult children can feel random, exposure to new ideas about families and one's own family and decisions to act differently emerge at predictable life-cycle moments. It ...
In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...
Okanogan County Emergency Management (OCEM) announced that Level 3 evacuation orders for the Brooks Tract Fire have been reduced to Level 1 advisory surrounding the immediate burn area, and all other ...
How CEOs can turn things around before decision-making breaks down and silos take hold. CEOs get a ton of credit or blame for a company’s performance. But the entire leadership team is vital to ...
WHEN THE Charter of the United Nations was signed, 80 years ago this week, President Harry Truman emphasised that the document’s value lay only in the will of governments to use it. “The job”, he said ...
TACE-HAlC combined with donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): A retrospective IPTW adjusted cohort study. This is an ASCO Meeting Abstract from the ...
In a 4.3-year follow-up study, few asymptomatic patients with preclinical left ventricular diastolic dysfunction (LVDD) progressed to heart failure with preserved ejection fraction (HFpEF), with a ...
Dr. Casey Means, President Trump's nominee to serve as the U.S. surgeon general, is a prominent proponent of Health and Human Services Secretary Robert F. Kennedy Jr.'s "MAHA," or "Make America ...
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results